Evidence map›Paper›PMID 18392872›Full record

ArticleLipids2008

N-3 polyunsaturated fatty acids modulate in-vitro T cell function in type I diabetic patients.

Sid Ahmed Merzouk, Meriem Saker, Karima Briksi Reguig, Nassima Soulimane, Hafida Merzouk, Baya Guermouche, Abdelsslam Yahia Berrouiguet, Aziz Hichami, Michel Narce, Naim Akhtar Khan

Abstract read
PubMed Publisher
In one paragraph

Article in Lipids, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Effect of cadmium exposure on essential omega-3 fatty acids in the edible bivalve Donax trunculus.Environmental science and pollution research international · 2018
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Sid Ahmed MerzoukDépartement de Physique, Faculté des Sciences, Université de Tlemcen, Tlemcen, Algeria.
Meriem Saker
Karima Briksi Reguig
Nassima Soulimane
Hafida Merzouk
Baya Guermouche
Abdelsslam Yahia Berrouiguet
Aziz Hichami
Michel Narce
Naim Akhtar Khan
University of Abou Bekr Belkaïd · DZCentre de recherche Translationnelle en Médecine moléculaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, we assessed the in-vitro effects of eicosapentaenoic acid (EPA; C20:5n-3) and docosahexaenoic acid (DHA; C22:6n-3) (final concentration, 15 microM) on T cell blastogenesis, interleukin-2 and -4 (IL-2, IL-4) secretion, fatty acid composition and intracellular oxidative status in type I diabetic patients with or without complications. Con A stimulated lymphocyte proliferation, glucose uptake, intracellular reduced glutathione levels and catalase activity were lower in diabetics as compared to controls, regardless to the presence of complications. EPA and DHA diminished T-lymphocyte proliferation and IL-2 production but enhanced IL-4 secretion in both diabetic and control groups. No changes in the levels of reduced glutathione and in the activities of catalase and SOD were observed in control T cells cultured in the presence of EPA and DHA. However, in diabetic patients, addition of n-3 PUFA to culture induced an increase in T cell levels of reduced glutathione and hydroperoxide, and in activities of catalase and SOD. Low levels of arachidonic acid (C20:4n-6) were found in plasma membrane phospholipids of lymphocytes from diabetic patients compared to controls. Incubation of lymphocytes with EPA and DHA was associated with an incorporation of these fatty acids in membrane phospholipids. In conclusion, the beneficial effects of n-3 PUFA on T cell functions in type I diabetes could be attributed to their suppressive action and modulation of cytokine secretion, and to the improvement of intracellular oxidative status.

Indexed as

AdultBlood GlucoseCholesterolDiabetes Mellitus, Type 1Fatty Acids, Omega-3FemaleGlutathioneGlycated HemoglobinHumansHydrogen PeroxideIn Vitro TechniquesMalePhospholipidsT-LymphocytesTriglyceridesBlood GlucoseCholesterolFatty Acids, Omega-3GlutathioneGlycated HemoglobinHydrogen PeroxidePhospholipidsTriglycerides

Identifiers

PMID18392872
OpenAlexW1970020878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.